Androgenetic Alopecia
Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial
The news follows positive phase 2a results for the androgenetic alopecia treatment
Innovative Medical Solutions for Postponing and Undoing Age-Related Disease
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related...
Innovative Medical Solutions for Postponing and Undoing Age-related Disease
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding...
Key role for French cluster in regenerative medicine project
Medicen Paris Region will be responsible for long-term impact of the BONE project
Astellas sets up regenerative medicine unit
Will spearhead company's efforts in cell-based therapies